An analysis of newspaper reports of cancer breakthroughs: Hope or hype?

Medical Journal of Australia

Volumn 179, Issue 11-12, 2003, Pages 639-643

  Ooi, Ethel S ^a   Chapman, Simon ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

105AD7; ACETYLSALICYLIC ACID; ACTIN; ANTIBODY; ANTINEOPLASTIC AGENT; CANCER VACCINE; GRANULOCYTE COLONY STIMULATING FACTOR; INTERFERON; INTERFERON A; MONOCLONAL ANTIBODY LM 609; PROTEIN P16; PROTEIN RET; PROTON; UNCLASSIFIED DRUG; VINCRISTINE; VIRUS PROTEIN;

AUSTRALIA; AUTOLOGOUS BONE MARROW TRANSPLANTATION; BEAM THERAPY; CANCER; CANCER CHEMOTHERAPY; CANCER RESEARCH; CLINICAL PRACTICE; CLINICAL TRIAL; CRYOTHERAPY; DRUG MEGADOSE; DRUG POTENCY; GENE THERAPY; HEALTH SURVEY; HUMAN; MASS MEDIUM; MEDLINE; MELANOMA; OUTCOMES RESEARCH; PUBLICATION; QUESTIONNAIRE; REVIEW; VACCINATION;

EID: 0348038802     PISSN: 0025729X     EISSN: None     Source Type: Journal    
DOI: 10.5694/j.1326-5377.2003.tb05728.x     Document Type: Review

References (48)

1. Lupton D. Medical and health stories on the Sydney Morning Herald's front page. Aust J Public Health 1995; 19: 501-508.
2. Burns RB, Moskowitz MA, Osband MA, Kazis LE. Newspaper reporting of the medical literature. J Gen Intern Med 1995; 10: 19-24.
3. Pentz RD, Flamm AL, Sugarman J, et al. Study of the media's potential influence on prospective research participants' understanding of and motivations for participation in a high-profile phase I trial. J Clin Oncol 2002; 20: 3785-3791.
4. Chen X, Siu LL. Impact of the media and the Internet on oncology: Survey of cancer patients and oncologists in Canada. J Clin Oncol 2001; 19: 4291-4297.
5. Benelli E. The role of the media in steering public opinion on health care issues. Health Policy 2003; 63: 179-186.
6. Moynihan R, Bero L, Ross-Degnan D, et al. Coverage by the news media of the benefits and risks of medications. N Engl J Med 2000; 342: 1645-1650.
7. Koren G, Klein N. Bias against negative studies in newspaper reports of medical research. JAMA 1991; 266: 1824-1826.
8. Olson CM, Rennie D, Cook D, et al. Publication bias in editorial decision making. JAMA 2002; 287: 2825-2828.
9. Crandall RL. Research funding and the media. JAMA 1991; 266: 1279, 1282.
10. Dow S. The politics of breast cancer. The Australian 1994 Apr 16-17; The Weekend Magazine: 35.
11. Entwistle V. Reporting research in medical journals and newspapers. BMJ 1995; 310: 920-923.
12. Van Trigt AM, De Jong-Van Den Berg LTW, Voogt LM, et al. Setting the agenda: Does the medical literature set the agenda for articles about medicines in the newpapers? Soc Sci Med 1995; 41: 893-899.
13. Van Trigt AM, De Jong-Van Den Berg LTW, Haaijer-Ruskamp FM, et al. Journalists and their sources of ideas and information on medicines. Soc Sci Med 1994; 38: 637-643.
14. De Semir V, Ribas C, Revuelta G. Press releases of science journal articles and subsequent newspaper stories on the same topic. JAMA 1998; 280: 294-295.
15. Stryker JE. Reporting medical information: Effects of press releases and newsworthiness on medical journal articles' visibility in the news media. Prev Med 2002; 35: 519-530.
16. Phillips DP, Kanter EJ, Bednarczyk B, Tastad PL. Importance of the lay press in the transmission of medical knowledge to the scientific community. N Engl J Med 1991; 325: 1180-1183.
17. Cornell RC, Greenway HT, Tucker SB, et al. Intralesional interferon therapy for basal cell carcinoma. J Am Acad Dermatol 1990; 23(4 Pt 1): 694-700.
18. Culver KW, Ram Z, Wallbridge S, et al. In vivo gene transfer with retroviral vector-producer cells for treatment of experimental brain tumors. Science 1992; 256: 1550-1552.
19. Morton DL, Foshag LJ, Hoon DS, et al. Prolongation of survival in metastatic melanoma after active specific immunotherapy with a new polyvalent melanoma vaccine. Ann Surg 1992; 216: 463-482.
20. Slater JM, Slater JD, Archambeau JO. Carcinoma of the tonsillar region: Potential for use proton beam therapy. Int J Radiat Oncol Biol Phys 1992; 22: 311-319.
21. Pecheniuk NM, Marsh N, Walsh TP, Dale JL. Use of first nucleotide change technology to determine the frequency of factor V Leiden in a population of Australian blood donors. Blood Coagul Fibrinolysis 1997; 8: 491-495.
22. Quek SC, Mould T, Canfell K, et al. The Polarprobe - Emerging technology for cervical cancer screening. Ann Acad Med Singapore 1998; 27: 717-721.
23. Buckley MF, Sweeney KJ, Hamilton JA, et al. Expression and amplification of cyclin genes in human breast cancer. Oncogene 1993; 8: 2127-2133.
24. Tindle RW, Fernando GJ, Sterling JC, Frazer IH. A "public" T-helper epitope of the E7 transforming protein of human papillomavirus 16 provides cognate help for several E7 B-cell epitopes from cervical cancer-associated human papillomavirus genotypes. Proc Natl Acad Sci U S A 1991; 88: 5887-5891.
25. Besnard-Guerin C, Cavenee WK, Newsham I. A new highly polymorphic DNA restriction site marker in the 5′ region of the human tyrosine hydroxylase gene (TH) detecting loss of heterozygosity in human embryonal rhabdomyosarcoma. Hum Genet 1994; 93: 349-350.
26. Thun MJ, Heath CW Jr. Aspirin use and reduced risk of gastrointestinal tract cancers in the American Cancer Society prospective studies. Prev Med 1995; 24: 116-118.
27. Healy DL, Burger HG, Mamers P, et al. Elevated serum inhibin concentrations in postmenopausal women with ovarian tumors. N Engl J Med 1993; 329: 1539-1542.
28. Thigpen JT, Bertelsen K, Eisenhauer EA, et al. Long-term follow-up of patients with advanced ovarian carcinoma treated with chemotherapy. Ann Oncol 1993; 4 Suppl 4: 35-40.
29. Vowels MR, Tang RL, Berdoukas V, et al. Brief report: Correction of X-linked lymphoproliferative disease by transplantation of cord-blood stem cells. N Engl J Med 1993; 329: 1623-1625.
30. Apostolopoulos V, Xing PX, McKenzie IF. Murine immune response to cells transfected with human MUC1: Immunization with cellular and synthetic antigens. Cancer Res 1994; 54: 5186-5193.
31. Pilbrow SJ, Hertzog PJ, Linnane AW. The adenoma-carcinoma sequence in the colorectum - Early appearance of a hierarchy of small intestinal mucin antigen (SIMA) epitopes and correlations with malignant potential. Br J Cancer 1992; 66: 748-757.
32. Telford DJ, Kavallaris M, White L, et al. Association of N-myc amplification with neuroblastoma: The Australian and New Zealand experience. J Paediatr Child Health 1992; 28: 58-63.
33. Kellie SJ, De Graaf SSN, Bloemhof H, et al. Neurotoxicity and pharmacokinetics of 96-h vincristine infusion in children with CNS tumors [abstract]. International Society of Pediatric Oncology, SIOP XXVII meeting; 1995 Oct 10-14; Montevideo, Uruguay. Med Pediatr Oncol 1995; 25: 258.
34. Holliger P, Prospero T, Winter G. "Diabodies": Small bivalent and bispecific antibody fragments. Proc Natl Acad Sci U S A 1993; 90: 6444-6448.
35. Preketes AP, King J, Caplehorn JR, et al. CEA reduction after cryotherapy for liver metastases from colon cancer predicts survival. Aust N Z J Surg 1994; 64: 612-614.
36. Newcomb PA, Storer BE, Longnecker MP, et al. Lactation and a reduced risk of premenopausal breast cancer. N Engl J Med 1994; 330: 81-87.
37. Denton GW, Durrant LG, Hardcastle JD, et al. Clinical outcome of colorectal cancer patients treated with human monoclonal anti-idiotypic antibody. Int J Cancer 1994; 57: 10-14.
38. Ford D, Easton DF, Bishop DT, et al. Risks of cancer in BRCA1-mutation carriers. Lancet 1994; 343: 692-695.
39. Musgrove EA, Lilischkis R, Cornish AL, et al. Expression of the cyclin-dependent kinase inhibitors p16INK4, p15INK4B and p21WAF1/CIP1 in human breast cancer. Int J Cancer 1995; 63: 584-591.
40. Hercus TR, Bagley CJ, Cambareri B, et al. Specific human granulocyte-macrophage colony-stimulating factor antagonists. Proc Natl Acad Sci U S A 1994; 91: 5838-5842.
41. Marsh DJ, Robinson BG, Andrew S, et al. A rapid screening method for the detection of mutations in the RET proto-oncogene in multiple endocrine neoplasia type 2A and familial medullary thyroid carcinoma families. Genomics 1994; 23: 477-479.
42. Faulkner SW, Leigh DA, Oosterhuis JW, et al. Allelic losses in carcinoma in situ and testicular germ cell tumours of adolescents and adults: Evidence suggestive of the linear progression model. Br J Cancer 2000; 83: 729-736.
43. Berek JS, Bast RC Jr. Ovarian cancer screening. The use of serial complementary tumor markers to improve sensitivity and specificity for early detection. Cancer 1995; 76(10 Suppl): 2092-2096.
44. De Silva R, Englezou A, Schevzov G, et al. Induction of anchorage independent growth and serum resistance in immortalized human bronchial epithelial cells by alteration of the cytoskeleton. Cell Mol Biol Res 1994; 40: 323-335.
45. Brooks PC, Montgomery AM, Rosenfeld M, et al. Integrin alpha v beta 3 antagonists promote tumor regression by inducing apoptosis of angiogenic blood vessels. Cell 1994; 79: 1157-1164.
46. Rowe SB. Food for thought: An in depth look at how the media report nutrition, food safety, and health. Am Med Writers Assoc J 2000; 15: 5-9.
47. Johnson T. Shattuck Lecture - Medicine and the mass media. N Engl J Med 1998; 339: 87-92.
48. Nelkin D. An uneasy relationship: The Tensions between medicine and the media. Lancet 1996; 347: 1600-1603.